Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
This study has been completed.
Study NCT00234741 Information provided by Synta Pharmaceuticals Corp.
First Received on October 5, 2005. Last Updated on December 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Inflammatory Bowel Diseases
Interventions listed in this trial
Sponsors listed in this trial
Synta Pharmaceuticals Corp.
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers